BACKGROUND: Prior work to integrate early palliative care in oncology has focused on patients with advanced cancer and primarily on palliative care consultation. We developed this outpatient clinic initiative for newly diagnosed patients at any stage, emphasizing primary (nonspecialist) palliative care by oncology teams, with enhanced access to palliative care specialists. METHODS: We piloted the project in two medical oncology specialty clinics (for patients with myelodysplastic syndrome and GI cancer, respectively) to establish feasibility. On a visit-based schedule, patients systematically reported symptoms, information/decision-making preferences, and illness understanding. They also participated in discussions of their core values with their oncology nurse. Oncology teams were first responders to palliative care needs, whereas specialists were available for clinician support and direct patient consultation. RESULTS: All 58 eligible patients were enrolled. In both clinics, patient self-reports documented a heavy symptom burden. Information/decision-making preferences and illness understanding levels varied across patients. Patients prepared new advance directives. Oncology nurses documented discussions of core values. Requests for palliative care consultation decreased over time as oncology teams embraced their primary palliative care role with coaching from the specialists. Clinic workflow and patient volume were maintained. CONCLUSION: Our pilot experience suggests that in outpatient oncology clinics, a structured, scheduled, and systematic approach is feasible to deliver palliative care to newly diagnosed patients with cancer at any stage and throughout their illness trajectory. This novel approach identified important, actionable palliative care needs, relying primarily on oncology teams to respond to these needs, while enhancing access to palliative care specialist input. Expansion to additional clinics will allow evaluation of scalability and generalizability, along with measurement of a broader range of important outcomes.
BACKGROUND: Prior work to integrate early palliative care in oncology has focused on patients with advanced cancer and primarily on palliative care consultation. We developed this outpatient clinic initiative for newly diagnosed patients at any stage, emphasizing primary (nonspecialist) palliative care by oncology teams, with enhanced access to palliative care specialists. METHODS: We piloted the project in two medical oncology specialty clinics (for patients with myelodysplastic syndrome and GI cancer, respectively) to establish feasibility. On a visit-based schedule, patients systematically reported symptoms, information/decision-making preferences, and illness understanding. They also participated in discussions of their core values with their oncology nurse. Oncology teams were first responders to palliative care needs, whereas specialists were available for clinician support and direct patient consultation. RESULTS: All 58 eligible patients were enrolled. In both clinics, patient self-reports documented a heavy symptom burden. Information/decision-making preferences and illness understanding levels varied across patients. Patients prepared new advance directives. Oncology nurses documented discussions of core values. Requests for palliative care consultation decreased over time as oncology teams embraced their primary palliative care role with coaching from the specialists. Clinic workflow and patient volume were maintained. CONCLUSION: Our pilot experience suggests that in outpatient oncology clinics, a structured, scheduled, and systematic approach is feasible to deliver palliative care to newly diagnosed patients with cancer at any stage and throughout their illness trajectory. This novel approach identified important, actionable palliative care needs, relying primarily on oncology teams to respond to these needs, while enhancing access to palliative care specialist input. Expansion to additional clinics will allow evaluation of scalability and generalizability, along with measurement of a broader range of important outcomes.
Authors: Ethan Basch; Allison M Deal; Amylou C Dueck; Howard I Scher; Mark G Kris; Clifford Hudis; Deborah Schrag Journal: JAMA Date: 2017-07-11 Impact factor: 56.272
Authors: Joan D Penrod; Partha Deb; Carol Luhrs; Cornelia Dellenbaugh; Carolyn W Zhu; Tsivia Hochman; Matthew L Maciejewski; Evelyn Granieri; R Sean Morrison Journal: J Palliat Med Date: 2006-08 Impact factor: 2.947
Authors: Thomas W LeBlanc; Jonathan D O'Donnell; Megan Crowley-Matoka; Michael W Rabow; Cardinale B Smith; Douglas B White; Greer A Tiver; Robert M Arnold; Yael Schenker Journal: J Oncol Pract Date: 2015-03 Impact factor: 3.840
Authors: Yael Schenker; Douglas White; Margaret Rosenzweig; Edward Chu; Charity Moore; Peter Ellis; Peggy Nikolajski; Colleen Ford; Greer Tiver; Lauren McCarthy; Robert Arnold Journal: J Palliat Med Date: 2014-12-17 Impact factor: 2.947
Authors: Ethan Basch; Allison M Deal; Mark G Kris; Howard I Scher; Clifford A Hudis; Paul Sabbatini; Lauren Rogak; Antonia V Bennett; Amylou C Dueck; Thomas M Atkinson; Joanne F Chou; Dorothy Dulko; Laura Sit; Allison Barz; Paul Novotny; Michael Fruscione; Jeff A Sloan; Deborah Schrag Journal: J Clin Oncol Date: 2015-12-07 Impact factor: 44.544
Authors: R Sean Morrison; Joan D Penrod; J Brian Cassel; Melissa Caust-Ellenbogen; Ann Litke; Lynn Spragens; Diane E Meier Journal: Arch Intern Med Date: 2008-09-08
Authors: Rajiv Agarwal; Elyse Shuk; Danielle Romano; Margaux Genoff; Yuelin Li; Eileen M O'Reilly; William Breitbart; Angelo E Volandes; Andrew S Epstein Journal: Support Care Cancer Date: 2019-06-13 Impact factor: 3.603
Authors: Andrew S Epstein; Anjali V Desai; Camila Bernal; Danielle Romano; Peter J Wan; Molly Okpako; Kelly Anderson; Kimberly Chow; Dana Kramer; Claudia Calderon; Virginia V Klimek; Robin Rawlins-Duell; Diane L Reidy; Jessica I Goldberg; Elizabeth Cruz; Judith E Nelson Journal: J Pain Symptom Manage Date: 2019-04-26 Impact factor: 3.612
Authors: Andrew S Epstein; Michael Riley; Judith E Nelson; Camila Bernal; Steven Martin; Han Xiao Journal: Cancer Date: 2022-07-22 Impact factor: 6.921
Authors: Lauren E Sigler; Andrew D Althouse; Teresa H Thomas; Robert M Arnold; Douglas White; Thomas J Smith; Edward Chu; Margaret Rosenzweig; Kenneth J Smith; Yael Schenker Journal: JCO Oncol Pract Date: 2021-11-12
Authors: Heather M Derry; Andrew S Epstein; Wendy G Lichtenthal; Holly G Prigerson Journal: Expert Rev Anticancer Ther Date: 2019-08-10 Impact factor: 4.512
Authors: Anjali Varma Desai; Chelsea L Michael; Gilad J Kuperman; Gregory Jordan; Haley Mittelstaedt; Andrew S Epstein; MaryAnn Connor; Rika Paula B Villar; Camila Bernal; Dana Kramer; Mary Elizabeth Davis; Yuxiao Chen; Catherine Malisse; Gigi Markose; Judith E Nelson Journal: J Med Internet Res Date: 2021-02-17 Impact factor: 5.428